Navigation Links
PediaVision CEO to Speak at FDA Workshop
Date:9/18/2012

LAKE MARY, Fla., Sept. 18, 2012 /PRNewswire/ --WHO: 

David Melnik, president & CEO of PediaVision, maker of the award-winning Spot vision screener.WHAT: 

Will provide an entrepreneurial view on how to achieve success when introducing new medical devices into the market.WHEN:Monday, September 24, 8:30 a.m.WHERE: 

FDA OOPD Pediatric Medical Devices WorkshopThe Great Room, White Oak Campus10903 New Hampshire Avenue, Silver Spring, Maryland  WORKSHOP: 

The Pediatric Devices Workshop is intended to address perceived challenges to pediatric device development, including how to successfully attract investors, businesses, and industry sponsors to invest in pediatric device development projects. See agenda at:https://events-support.com/Documents/Agenda_FDA_PMD.pdfPEDIAVISION:Maker of the revolutionary technology, Spot, a portable, handheld, wireless, WiFi-enabled, binocular vision screening device that can screen anyone 6 months of age and up in just a few seconds.


'/>"/>
SOURCE PediaVision
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
2. eCardios CEO to Speak During "Act at the Speed of Opportunity" Event Presented by Comcast Business Class and Inc.
3. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
4. Accuray Incorporated to Speak at Wells Fargo Healthcare Conference
5. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
6. Dr. Darlene McCord To Speak At Gildas Club Of The Quad Cities "Lunch and Learn" Hosted By Pinnaclife, Inc.
7. Speakers Announced for the 2012 International Iridoid Research Symposium
8. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
9. Two Top Notch Cadaver Workshops Offered by joimax® in April
10. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
11. Talyst Holds User Group Meeting & Two-Day Customer Education Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):